/PRNewswire/ SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced today.
- On November 28th, the board of directors decided to invest in the expansion of L HOUSE, a vaccine manufacturing plant of SK bioscience in Andong, South Korea to approximately.
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing agreement with Hilleman Laboratories, a vaccines and biologics.
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that H.E Dr. Jean Kaseya, Director General of Africa CDC visited SK bioscience headquarters on November 3 to discuss collaboration with the Partnerships for African Vaccine Manufacturing (PAVM).